In contrast, Urashima et al. demonstrated that tapinarof suppressed IL-23-induced psoriasis-like dermatitis in mice, reducing ear thickness, inflammatory cell infiltration, and pro-inflammatory cytokine expression. The gene discussed is IL37; the disease is psoriasis.